Literature DB >> 33533351

A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer.

Jing Zhang1, Ningning Wang1, Qian Li1, Yaxin Zhou1, Yuxia Luan1.   

Abstract

A two-pronged concept combining photodynamic therapy (PDT) and epithelial-mesenchymal transition (EMT) blockade in a minimalist nanoplatform was proposed to combat basal-like breast cancer (BLBC) metastasis. Based on PDT-mediated tumor killing and epalrestat (Epa)-mediated EMT blockade, as-prepared Ce6/Epa nanoparticles prevented BLBC metastasis effectively in vivo, providing a very promising two-pronged strategy against BLBC metastasis.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33533351     DOI： 10.1039/d0cc08162k

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  11 in total

Review 1.  Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy.

Authors:  Bin Ji; Minjie Wei; Bin Yang
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

2.  Dasatinib self-assembled nanoparticles decorated with hyaluronic acid for targeted treatment of tumors to overcome multidrug resistance.

Authors:  Yawen Zhang; Xiangle Zeng; Hairong Wang; Ranran Fan; Yike Hu; Xuejie Hu; Jianchun Li
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

3.  Formulation and Evaluation of Luteolin-Loaded Nanovesicles: In Vitro Physicochemical Characterization and Viability Assessment.

Authors:  Syed Sarim Imam; Sultan Alshehri; Mohammad A Altamimi; Afzal Hussain; Khaled Hamad Alyahya; Wael A Mahdi; Wajhul Qamar
Journal:  ACS Omega       Date:  2021-12-23

4.  A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy.

Authors:  Yun-Chang Zhang; Pei-Yu Zeng; Zhi-Qiang Ma; Zi-Yue Xu; Ze-Kun Wang; Beibei Guo; Feng Yang; Zhan-Ting Li
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

5.  Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors.

Authors:  Xin Yang; Yifan Wang; Si Chen; Shuang Zhang; Chunying Cui
Journal:  Int J Nanomedicine       Date:  2021-10-16

6.  Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.

Authors:  Fangyuan Guo; Nan Yu; Yunlong Jiao; Weiyong Hong; Kang Zhou; Xugang Ji; Huixing Yuan; Haiying Wang; Aiqin Li; Guoping Wang; Gensheng Yang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

7.  Prodrug-based nano-delivery strategy to improve the antitumor ability of carboplatin in vivo and in vitro.

Authors:  Tingting Lang; Nuannuan Li; Jing Zhang; Yi Li; Rong Rong; Yuanlei Fu
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

Review 8.  PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application.

Authors:  Yue Su; Bolun Zhang; Ruowei Sun; Wenfang Liu; Qubo Zhu; Xun Zhang; Rongrong Wang; Chuanpin Chen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

9.  A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy.

Authors:  Yun-Chang Zhang; Pei-Yu Zeng; Zhi-Qiang Ma; Zi-Yue Xu; Ze-Kun Wang; Beibei Guo; Feng Yang; Zhan-Ting Li
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

10.  Synergistic Analysis of Circulating Tumor Cells Reveals Prognostic Signatures in Pilot Study of Treatment-Naïve Metastatic Pancreatic Cancer Patients.

Authors:  Sarah Owen; Emily Prantzalos; Valerie Gunchick; Vaibhav Sahai; Sunitha Nagrath
Journal:  Biomedicines       Date:  2022-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.